Wells Fargo & Company Raises Omega Healthcare Investors (NYSE:OHI) Price Target to $44.00

Key Points

• Wells Fargo & Company has raised the price target for Omega Healthcare Investors (NYSE:OHI) from $41.00 to $44.00, indicating a potential upside of 4.39% from the stock's previous close.
• Royal Bank of Canada also updated their price target for Omega Healthcare Investors to $41.00 while maintaining a "sector perform" rating.
• As of the latest report, Omega Healthcare Investors has a consensus rating of "Moderate Buy" with four analysts rating it as a Buy and four as a Hold.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) had its price objective raised by equities research analysts at Wells Fargo & Company from $41.00 to $44.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an "overweight" rating on the real estate investment trust's stock. Wells Fargo & Company's price target would suggest a potential upside of 4.39% from the stock's previous close.

Separately, Royal Bank Of Canada raised their price objective on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research report on Thursday, August 7th. Four equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $42.86.

Omega Healthcare Investors Trading Up 0.4%

Shares of NYSE:OHI traded up $0.16 during midday trading on Wednesday, reaching $42.15. The company's stock had a trading volume of 190,718 shares, compared to its average volume of 2,380,820. The firm has a market cap of $12.43 billion, a price-to-earnings ratio of 26.02, a price-to-earnings-growth ratio of 2.23 and a beta of 0.66. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors has a 1 year low of $35.04 and a 1 year high of $44.42. The business has a 50 day moving average price of $38.73 and a 200 day moving average price of $37.66.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The firm had revenue of $235.60 million for the quarter, compared to analysts' expectations of $248.49 million. During the same quarter last year, the firm earned $0.71 earnings per share. The firm's revenue for the quarter was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Research analysts forecast that Omega Healthcare Investors will post 2.86 EPS for the current year.

Insider Buying and Selling

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the transaction, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.50% of the company's stock.

Hedge Funds Weigh In On Omega Healthcare Investors

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Caitong International Asset Management Co. Ltd acquired a new position in Omega Healthcare Investors in the second quarter valued at approximately $26,000. NBC Securities Inc. acquired a new position in Omega Healthcare Investors in the first quarter valued at approximately $29,000. Smartleaf Asset Management LLC boosted its stake in Omega Healthcare Investors by 40.9% in the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust's stock valued at $34,000 after acquiring an additional 268 shares during the period. CENTRAL TRUST Co boosted its stake in Omega Healthcare Investors by 1,654.4% in the second quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust's stock valued at $37,000 after acquiring an additional 943 shares during the period. Finally, Cullen Frost Bankers Inc. acquired a new position in Omega Healthcare Investors in the second quarter valued at approximately $41,000. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.